Literature DB >> 1713258

Characterization and comparative bactericidal activity of monoclonal antibodies to Bordetella pertussis lipo-oligosaccharide A.

D Archambault1, P Rondeau, D Martin, B R Brodeur.   

Abstract

Spleen cells from mice immunized with a Bordetella pertussis N-lauroyl sarcosine membrane extract (SME) were used to generate hybridoma cells lines producing monoclonal antibodies (mAbs). Seven mAbs were shown to be specific to B. pertussis lipo-oligosaccharide (LOS) by immunoblotting of SME or purified LOS following SDS-PAGE. All mAbs reacted with the B. pertussis Tohama I strain of the LOS AB phenotype, and did not react with the atypical variant strain 134 of the LOS B phenotype. The immune reactivity of the mAbs was retained after treatment of SME with proteinase K and was lost after sodium periodate treatment. No cross-reactivity was observed with the mAbs when tested against B. parapertussis and other Gram-negative bacteria. However, all mAbs reacted with B. bronchiseptica. Binding assays with live B. pertussis cells demonstrated that mAbs strongly reacted with cell surface exposed antigenic determinants. High bacterial cell lytic capability was observed for five of these mAbs. Concentrations between 0.22 and 2.2 micrograms mAb ml-1 (0.1 and 1 microgram per 450 microliter assay) purified by protein A were required to kill at least 50% of the bacteria. Competition immunoassays with biotinylated antibodies showed that the bacteriolytic and non-bacteriolytic mAbs were directed to different epitopes of the B. pertussis LOS A.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1713258     DOI: 10.1099/00221287-137-4-905

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  11 in total

1.  Immunological characterization of the lipooligosaccharide B band of Bordetella pertussis.

Authors:  D Martin; M S Peppler; B R Brodeur
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

2.  An improved immunofluorescent reagent for rapid, direct detection of Bordetella pertussis.

Authors:  D Martin; P McNicol; R Marchand; P Lebel; M S Peppler; B R Brodeur
Journal:  Can J Infect Dis       Date:  1995-01

3.  Toward a new vaccine for pertussis.

Authors:  John B Robbins; Rachel Schneerson; Joanna Kubler-Kielb; Jerry M Keith; Birger Trollfors; Evgeny Vinogradov; Joseph Shiloach
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-20       Impact factor: 11.205

4.  Identification of two bvg-repressed surface proteins of Bordetella pertussis.

Authors:  T H Stenson; M S Peppler
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

Review 5.  Antigenic analysis of the saccharide moiety of the lipooligosaccharide of Bordetella pertussis.

Authors:  B R Brodeur; D Martin; J Hamel; R D Shahin; C Laferrière
Journal:  Springer Semin Immunopathol       Date:  1993

6.  Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine.

Authors:  Joanna Kubler-Kielb; Evgeny Vinogradov; Teresa Lagergård; Ariel Ginzberg; Jerry D King; Andrew Preston; Duncan J Maskell; Vince Pozsgay; Jerry M Keith; John B Robbins; Rachel Schneerson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-22       Impact factor: 11.205

7.  Interactions of pulmonary collectins with Bordetella bronchiseptica and Bordetella pertussis lipopolysaccharide elucidate the structural basis of their antimicrobial activities.

Authors:  Lyndsay M Schaeffer; Francis X McCormack; Huixing Wu; Alison A Weiss
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

8.  Analysis of protective and nonprotective monoclonal antibodies specific for Bordetella pertussis lipooligosaccharide.

Authors:  R D Shahin; J Hamel; M F Leef; B R Brodeur
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

9.  Structural characterization of the lipid A of Bordetella pertussis 1414 endotoxin.

Authors:  M Caroff; C Deprun; J C Richards; D Karibian
Journal:  J Bacteriol       Date:  1994-08       Impact factor: 3.490

10.  A bactericidal monoclonal antibody specific for the lipooligosaccharide of Bordetella pertussis reduces colonization of the respiratory tract of mice after aerosol infection with B. pertussis.

Authors:  K T Mountzouros; A Kimura; J L Cowell
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.